A systems-approach to NAD+ restoration
Authors:
- Nichola ConlonNCNichola Conlon
- Dianne FordDFDianne Ford
Open Access
- 5 February 2022
- journal article
- review article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 198
Abstract
No abstract availableKeywords
This publication has 129 references indexed in Scilit:
- Neuroprotective efficacy of aminopropyl carbazoles in a mouse model of amyotrophic lateral sclerosisProceedings of the National Academy of Sciences, 2012
- The NAD+ Precursor Nicotinamide Riboside Enhances Oxidative Metabolism and Protects against High-Fat Diet-Induced ObesityCell Metabolism, 2012
- Nicotinamide Mononucleotide, a Key NAD+ Intermediate, Treats the Pathophysiology of Diet- and Age-Induced Diabetes in MiceCell Metabolism, 2011
- PARP-2 Regulates SIRT1 Expression and Whole-Body Energy ExpenditureCell Metabolism, 2011
- Poly(ADP-ribose) polymerase 3 (PARP3), a newcomer in cellular response to DNA damage and mitotic progressionProceedings of the National Academy of Sciences, 2011
- Sirt3 Mediates Reduction of Oxidative Damage and Prevention of Age-Related Hearing Loss under Caloric RestrictionCell, 2010
- Interdependence of AMPK and SIRT1 for Metabolic Adaptation to Fasting and Exercise in Skeletal MuscleCell Metabolism, 2010
- Exercise alters SIRT1, SIRT6, NAD and NAMPT levels in skeletal muscle of aged ratsMechanisms of Ageing and Development, 2010
- Nampt/PBEF/Visfatin Regulates Insulin Secretion in β Cells as a Systemic NAD Biosynthetic EnzymeCell Metabolism, 2007
- Nutrient-Sensitive Mitochondrial NAD+ Levels Dictate Cell SurvivalCell, 2007